Antibiotic Regulatory Affairs

Ever since the discovery of antibiotics, the quality of human life greatly improved in the 20th century. The discovery of penicillin transformed the medicine industry and initiated a search for a better antibiotic every time resulting in several synthetic and semi-synthetic antibiotics. Beginning with the 1937 sulfa drug tragedy, the drug regulations had a parallel growth along with the antibiotics and the antibiotic-based generic Pharma industries. Several regulatory aspects involved with these industries have been discussed along with the complexity of the market, issues that could affect their growth, their struggle for quality, and their compliance with the tightened regulations. With the skyrocketing commercialization of antibiotics through generics and the leveraging technologic renaissance, generic industries are involved in providing maximum safer benefits for the welfare of the people, highlighting its need today.

 

    Related Conference of Antibiotic Regulatory Affairs

    July 01-02, 2019

    11th International Virology Summit

    Valencia, spain
    July 26-27, 2019

    World Yeast Congress

    Vancouver | Canada
    August 19-20, 2019 ,

    14th International Conference on Microbial Interactions & Microbial Ecology

    Mercure Hotel Wien Westbahnhof ,Vienna, Austria
    October 21-22, 2019

    6th World Congress and Expo on Applied Microbiology

    Rome, Italy
    October 23-24, 2019

    2nd Global Experts Meeting on Chronic Diseases

    Tokyo, Japan
    November 06-07, 2019 |

    15th Global Summit on Virology and Microbiology

    Yokohama | Japan
    November 14-15, 2019

    23rd World Congress on Biotechnology

    Amsterdam, Netherlands
    December 04-05, 2019

    Orthodontics and Prosthodontics

    Tokyo, Japan

    Antibiotic Regulatory Affairs Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in